New Speakers from Abingworth, Nasdaq, UCSF, and More!

Feel the pulse of the flourishing biotechnology industry with the latest updates from Abingworth, the FDA, Kite Pharma, Nasdaq, Qiming, ROTH Capital Partners, and more. We've recruited the industry's best thought leaders and local investment community to join us next week for BIO Investor Forum Digital. Here are some of the can't-miss speakers and sessions featured in the educational program.

  • David Berry, MD, PhD, Founder, CEO, Valo Health; General Partner, Flagship Pioneering
  • John D. Carpten, PhD, Institute of Translational Genomics, Keck School of Medicine of USC
  • Charles K. Fisher, Founder & CEO, Unlearn.AI
  • Julie Gerberding, MD, MPH, Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, Merck
  • Otello Stampacchia, PhD, Managing Director Omega Funds
  • Ethan Weiss, Associate Professor, UCSF



New Education Pass Starting at $200

Starting at just $200 for BIO Members, the new Education-Only Access Pass* gives you access to 20 interactive educational sessions and fireside chats, 130+ company presentations, and our new Topic-Driven Networking Series where you can virtually interact with a small group, organized by therapeutic area.